Mineralocorticoid receptor antagonists (MRAs)
- Block aldosterone signaling
- HFrEF: spironolactone/eplerenone improve survival
- Resistant HTN: spironolactone highly effective
- Finerenone: CKD/T2DM + HF indications
- Hyperkalemia + renal monitoring are central
- Spironolactone → gynecomastia/sexual AEs
- Eplerenone is more receptor-selective
Class at a glance
- Block aldosterone signaling
Clinical role
- HFrEF: spironolactone/eplerenone improve survival
- Eplerenone is more receptor-selective
Other clinical roles
- Resistant HTN: spironolactone highly effective
- Finerenone: CKD/T2DM + HF indications
- Spironolactone → gynecomastia/sexual AEs
Safety / monitoring
- Hyperkalemia + renal monitoring are central
Self-check
- What are key clinical uses of finerenone?
CKD/T2DM and HF indications.
Drugs in this class (3)
All drug classes · Open the interactive console ↗
